ArticleOpen research Europe2021

The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients.

Patty P A Dhooge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.